These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 16334111)

  • 21. Combining routine morphology, p16(INK4a) immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: a tissue microarray study using classifier performance analyses.
    Chaux A; Cubilla AL; Haffner MC; Lecksell KL; Sharma R; Burnett AL; Netto GJ
    Urol Oncol; 2014 Feb; 32(2):171-7. PubMed ID: 23499169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of immunohistochemistry for p16INK4 and high-risk HPV DNA by in situ hybridization in esophageal squamous cell carcinoma.
    Malik SM; Nevin DT; Cohen S; Hunt JL; Palazzo JP
    Int J Surg Pathol; 2011 Feb; 19(1):31-4. PubMed ID: 21087981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
    Walts AE; Lechago J; Bose S
    Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome.
    Kuo KT; Hsiao CH; Lin CH; Kuo LT; Huang SH; Lin MC
    Mod Pathol; 2008 Apr; 21(4):376-86. PubMed ID: 18223558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
    Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
    Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of human papillomavirus in squamous cell metaplasia-dysplasia-carcinoma of the rectum.
    Kong CS; Welton ML; Longacre TA
    Am J Surg Pathol; 2007 Jun; 31(6):919-25. PubMed ID: 17527081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas.
    Hafkamp HC; Manni JJ; Haesevoets A; Voogd AC; Schepers M; Bot FJ; Hopman AH; Ramaekers FC; Speel EJ
    Int J Cancer; 2008 Jun; 122(12):2656-64. PubMed ID: 18360824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
    Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
    Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency and role of HPV in the progression of epithelial dysplasia to oral cancer.
    Angiero F; Gatta LB; Seramondi R; Berenzi A; Benetti A; Magistro S; Ordesi P; Grigolato P; Dessy E
    Anticancer Res; 2010 Sep; 30(9):3435-40. PubMed ID: 20944119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of p16(INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue.
    Harris SL; Thorne LB; Seaman WT; Hayes DN; Couch ME; Kimple RJ
    Head Neck; 2011 Nov; 33(11):1622-7. PubMed ID: 21990227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancer.
    Tertipis N; Hammar U; Näsman A; Vlastos A; Nordfors C; Grün N; Ährlund-Richter A; Sivars L; Haeggblom L; Marklund L; Hammarstedt-Nordenvall L; Chaturvedi AK; Munck-Wikland E; Ramqvist T; Bottai M; Dalianis T
    Eur J Cancer; 2015 Aug; 51(12):1580-7. PubMed ID: 26025766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome.
    Charfi L; Jouffroy T; de Cremoux P; Le Peltier N; Thioux M; Fréneaux P; Point D; Girod A; Rodriguez J; Sastre-Garau X
    Cancer Lett; 2008 Feb; 260(1-2):72-8. PubMed ID: 18060686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice.
    Thavaraj S; Stokes A; Guerra E; Bible J; Halligan E; Long A; Okpokam A; Sloan P; Odell E; Robinson M
    J Clin Pathol; 2011 Apr; 64(4):308-12. PubMed ID: 21345874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience.
    Singhi AD; Westra WH
    Cancer; 2010 May; 116(9):2166-73. PubMed ID: 20186832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P16INK4a expression, human papillomavirus, and survival in head and neck cancer.
    Smith EM; Wang D; Kim Y; Rubenstein LM; Lee JH; Haugen TH; Turek LP
    Oral Oncol; 2008 Feb; 44(2):133-42. PubMed ID: 17360226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus and DNA ploidy in tonsillar cancer--correlation to prognosis.
    Mellin H; Friesland S; Auer G; Dalianis T; Munck-Wikland E
    Anticancer Res; 2003; 23(3C):2821-8. PubMed ID: 12926119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.
    Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B
    Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions.
    Huang MZ; Li HB; Nie XM; Wu XY; Jiang XM
    Diagn Cytopathol; 2010 Aug; 38(8):573-8. PubMed ID: 19941368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of HPV in head and neck tumours: high prevalence in tonsillar localization.
    Venuti A; Badaracco G; Rizzo C; Mafera B; Rahimi S; Vigili M
    J Exp Clin Cancer Res; 2004 Dec; 23(4):561-6. PubMed ID: 15743024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.